Which second-line treatment regimen should be used following relapse of platinum-sensitive ovarian cancer?

被引：0
|
作者：
Pecorelli, Sergio
Odicino, Franco
机构：
[1] Univ Brescia, Dept Obstet & Gynecol, Div Gynecol Oncol, I-25123 Brescia, Italy
[2] Univ Brescia, Dept Obstet & Gynecol, Brescia, Italy
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2007年 / 4卷 / 06期
关键词：
carboplatin; gemcitabine; ovarian cancer; progression-free survival; response rate;
D O I：
10.1038/ncponc0795
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：340 / 341
页数：2
相关论文
共 50 条
  • [11] Maintenance with Trabectedin in the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer
    Guerra Alia, Eva Maria
    Sempere Ortega, Cayetano
    Cortes Salgado, Alfonso
    Sanchez Martinez, Concepcion
    Galindo Alvarez, Julio
    Perez Miez, Belen
    CASE REPORTS IN ONCOLOGY, 2019, 12 (02): : 447 - 455
  • [12] Optimizing treatment of the partially platinum-sensitive ovarian cancer patient
    Colombo, Nicoletta
    FUTURE ONCOLOGY, 2013, 9 (12) : 19 - 23
  • [13] Second-line chemotherapy with gemcitabine and carboplatin in paclitaxel-pretreated, platinum-sensitive ovarian cancer patients - A Hellenic Cooperative Oncology Group Study
    Papadimitriou, CA
    Fountzilas, G
    Aravantinos, G
    Kalofonos, C
    Moulopoulos, LA
    Briassoulis, E
    Gika, D
    Dimopoulos, MA
    GYNECOLOGIC ONCOLOGY, 2004, 92 (01) : 152 - 159
  • [14] Second-line treatment with Topotecan in ovarian cancer
    Morales, S
    Balil, A
    Salud, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S87 - S87
  • [15] Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles
    Kim, Se Ik
    Hwang, Woo Yeon
    Lee, Maria
    Kim, Hee Seung
    Kim, Kidong
    Chung, Hyun Hoon
    No, Jae Hong
    Kim, Jae-Weon
    Kim, Yong Beom
    Park, Noh Hyun
    Song, Yong-Sang
    Suh, Dong Hoon
    BMC CANCER, 2020, 20 (01)
  • [16] Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles
    Se Ik Kim
    Woo Yeon Hwang
    Maria Lee
    Hee Seung Kim
    Kidong Kim
    Hyun Hoon Chung
    Jae Hong No
    Jae-Weon Kim
    Yong Beom Kim
    Noh Hyun Park
    Yong-Sang Song
    Dong Hoon Suh
    BMC Cancer, 20
  • [17] How should we manage patients with "platinum-sensitive" recurrent ovarian cancer?
    Ledermann, JA
    Wheeler, S
    CANCER INVESTIGATION, 2004, 22 : 2 - 10
  • [18] REPEATED USE OF MAINTENANCE THERAPY OLAPARIB IN PATIENTS WITH PLATINUM-SENSITIVE RELAPSE OF OVARIAN CANCER
    Khokhlova, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A478 - A478
  • [19] Platinum re-treatment as a second-line option for clinically and molecularly defined platinum-sensitive metastatic non-small cell lung cancer (NSCLC)
    de Lima Araujo, L. H.
    Terra, S. B. S. P.
    Pires, A. R. C.
    Small, I. A.
    Melo, A. C. D.
    Sternberg, C.
    Ferreira, C. G. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [20] Novel treatment options in platinum-sensitive recurrent ovarian cancer: A review
    Mullen, Mary M.
    Kuroki, Lindsay M.
    Thaker, Premal H.
    GYNECOLOGIC ONCOLOGY, 2019, 152 (02) : 416 - 425
12345